Found: 1
Select item for more details and to access through your institution.
Tixagevimab and Cilgavimab (Evusheld) Boosts Antibody Levels to SARS-CoV-2 in End-Stage Renal Disease Patients on Chronic Hemodialysis: A Single-Center Study.
- Published in:
- Medicina (1010660X), 2023, v. 59, n. 12, p. 2109, doi. 10.3390/medicina59122109
- By:
- Publication type:
- Article